Stock screener

NPCE

Conviction 100HealthcareScan · Thu, Jun 25, 2026
NPCE$16.36+0.86%
ResistanceSupportVol 14
63 bars
Vol MA14 160.05K
Mar 26Apr 14May 1May 19Jun 8Jun 25
NeuroPace IncSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.neuropace.com
Price16.36
Change+0.86%
Gap+1.91%
Rel volume2.67×
Avg volume162.65K
Avg $ vol2.6M
SMA 2015.93
SMA 5016.34
SMA 20014.40
Price vs 50+0.11%
Price vs 200+13.58%
MA stackbullish
50/200 cross
Supertrenddown · 17.66
RSI (14)55
MACD hist0.07
MACD crossbull · 1d
Stoch %K / %D76 / 63
ADX (14)11
+DI / −DI23 / 18
RSI divergence
MACD divergence
ATR %+4.78%
ADR %4.77%
52w high19.29
52w low8.25
From 52w high-15.19%
Above 52w low+98.30%
New 52w highNo
SqueezeOn · 1d
Bollinger width13.52%
%B0.70
Donchian pos53.43%
Donchian high17.65
Donchian low14.88
AVWAP (52w high)16.18
vs AVWAP high+1.08%
AVWAP (52w low)14.10
vs AVWAP low+16.07%
OBV trendFlat
Chaikin MF (20)-0.24
Today vs 20d2.67×
Avg vol (14d)160.05K
Avg vol (20d)162.65K
Avg $ vol (20d)2.6M
Market cap557.77M
RS 3m (vs SPY)+9.97%
RS 6m (vs SPY)-9.97%
RS line new highNo
Trend template8/8
Technical rank55.9
1 week+7.92%
1 month-1.92%
3 months+20.92%
6 months-1.21%
1 year+52.04%
YTD+7.84%
P/E-25.99
P/B38.59
P/S5.58
P/FCF-49.20
EPS-0.6600
Div yield
ROE-148.51%
ROA-21.70%
Debt/Eq4.08
Current5.38
EV/EBITDA
Gross margin77.23%
Net margin-21.47%
Rev growth25.13%
EPS growth20.91%
Price target
Target upside
Analyst rating
Institutional
Ent. value602.02M
Revenue22.07M
Net income-6.69M
Gross profit18.05M
Free cash flow-11.34M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out34.09M
Employees220
ListedThu, Apr 22, 2021
Free float22.03M
Float %66.1%
Short interest582.94K
Days to cover3.9d
Short volume44.5%
Squeeze score43 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank55.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance18.62
Support14.27
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NPCE

All disclosures →
No recent disclosed trades by Congress in NPCE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NPCE · 9 buys · 1 sell

InsiderSideShares
Morrell Martha
CHIEF MEDICAL OFFICER · Common Stock · 2026-06-24
Tax335
Fischer Frank M
Director · Common Stock · 2026-06-19
Grant1.47K
Geiger Uri
Director · Common Stock · 2026-06-19
Grant789
Kumar Rakhi
Director · Common Stock · 2026-06-19
Grant989
Fischer Frank M
Director · Common Stock · 2026-06-05
Grant2.89K
Huennekens R Scott
Director · Stock Option (Right to Buy) · 2026-06-05
Grant5.37K
Geiger Uri
Director · Stock Option (Right to Buy) · 2026-06-05
Grant5.37K
Geiger Uri
Director · Common Stock · 2026-06-05
Grant2.89K
Kumar Rakhi
Director · Common Stock · 2026-06-05
Grant2.89K
Ryan Renee
Director · Stock Option (Right to Buy) · 2026-06-05
Grant5.37K

SEC filings

EDGAR filings in NPCE · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.